Healthcare Transactions and Regulatory
The combination of our senior transactional counsel and our regulatory expertise makes us valued counsel in closing healthcare industry mergers, acquisitions, joint ventures, affiliations and other collaborations. Our practice is national in scope and involves all substantive aspects of healthcare transactions, including multistate regulatory approvals, legal risk assessments, tax structuring, antitrust analysis, and public company and going-private issues.
August 3, 2026
DOJ Announces the First Declination of a Healthcare Provider Under the New Corporate Enforcement Policy
March 26, 2025
Saudi Arabia Permits Foreign Investment in Pharmacies
March 25, 2025
Health Headlines – March 25, 2025
August 4, 2026
Healthcare Regulatory and Investigations Partner Troy Barsky Joins King & Spalding in Washington, D.C.
July 14, 2026
Rick Zall discusses the evolving role of healthcare transaction lawyers
December 5, 2024
Sage Secures $35 Million Series B Funding